Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2008. Start Trial.
Date Value
December 31, 2025 -117.6%
September 30, 2025 -1.95K%
June 30, 2025 -192.9%
March 31, 2025 -40.00%
December 31, 2024 0.00%
September 30, 2024
June 30, 2024 -163.6%
March 31, 2024 -26.09%
December 31, 2023 0.00%
September 30, 2023 -10.04K%
June 30, 2023 76.70%
March 31, 2023
September 30, 2018 13.27%
June 30, 2018 18.94%
March 31, 2018 18.46%
December 31, 2017 -80.53%
September 30, 2017 24.21%
June 30, 2017 21.89%
March 31, 2017 21.34%
December 31, 2016 21.31%
September 30, 2016 37.95%
June 30, 2016 36.64%
March 31, 2016 41.08%
December 31, 2015 25.98%
September 30, 2015 49.39%
Date Value
June 30, 2015 34.48%
March 31, 2015 38.60%
December 31, 2014 -31.25%
September 30, 2014 21.56%
June 30, 2014 21.95%
March 31, 2014 27.08%
December 31, 2013 -0.44%
September 30, 2013 26.68%
June 30, 2013 26.71%
March 31, 2013 25.10%
December 31, 2012 35.28%
September 30, 2012 39.09%
June 30, 2012 50.42%
March 31, 2012 87.80%
December 31, 2011 87.58%
September 30, 2011 87.49%
June 30, 2011 89.52%
March 31, 2011 87.02%
December 31, 2010 87.26%
September 30, 2010
June 30, 2010
March 31, 2010
December 31, 2009
September 30, 2009
June 30, 2009 -7.69%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Quest Diagnostics, Inc. 32.53%
Labcorp Holdings, Inc. 27.71%
OPKO Health, Inc. 37.32%
Psychemedics Corp. --
NeoGenomics, Inc. 44.06%

Gross Profit Margin (Quarterly) Related Metrics